SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.33-8.6%Jan 16 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (9319)3/23/1999 8:49:00 PM
From: Cacaito  Read Replies (1) of 17367
 
Robert S, please excuse me one mistake, correction to follow.

"Protein C, and activated protein C could lead to massive hypercoagulation (the opposite of AIII) same problem of effective dose to near the toxic dose."

Protein C is actually used in hypercoagulation states and help disolve clots, this feature is the same of tpa, and AIII (at different levels), and the reason it could be of help in the coagulation fase of DIC (disseminated intravascular coagulation) that is seen in many severe septic patients. It could be a good combination with BPI (if both are proven effective in sepsis). My bias is Bpi.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext